
As Rigetti Computing (RGTI) accelerates its global quantum computing ambitions, the recent strategic partnerships have raised questions about intellectual property (IP) protection, cross-border technology transfer, and regulatory oversight.
With quantum computing poised to reshape industries from defence to pharmaceuticals, the stakes surrounding IP and policy compliance have never been higher.